Skip to content

Other

Oxedrine [BAN]

CAS 94-07-5
35

Safety score · 0–100

Caution

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

Oxedrine [ban] is a cosmetic ingredient used in product formulations. Exercise caution due to limited available safety data.

Oxedrine is an alternate naming reference for synephrine (para-synephrine) with the same CAS number (94-07-5). The safety assessment, concerns, and EU regulatory status are identical to synephrine as described above. Cardiovascular caution is advised when used in cosmetic formulations at elevated concentrations.

Skin benefits

  • Vasoconstrictive effects may temporarily firm skin appearance
  • Used in anti-cellulite and slimming formulations

Known concerns

  • Cardiovascular effects (vasoconstriction, blood pressure elevation)
  • Interaction with caffeine and cardiovascular medications
  • Regulatory scrutiny similar to ephedrine-class compounds

References

EU

EU CosIng database

European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.

Related others

35
1,3-Benzenediamine, 4-methyl-, hydrochloride (1:1)
Other
 35
1,5-Di-(beta-hydroxyethylamino)-2-nitro-4-chlorobenzene (see note 17)
Other
 35
2,2'-Methylenebis(6-bromo-4-chlorophenol)
Other
 35
2,4-DIAMINO-5-METHYLPHENETOLE HCL
Other
 35
2-CHLORO-6-ETHYLAMINO-4-NITROPHENOL
Other
 35
2-Ethylhexyl 4-(dimethylamino)benzoate / Padimate O (USAN:BAN)
Other
 35
3-(p-Chlorophenoxy)-propane-1,2-diol
Other
 35
3-Hydroxy-N-(o-tolyl)-4-[(2,4,5-trichlorophenyl)azo]naphthalene-2-carboxamide
Other

Check your shelf

Find Oxedrine [BAN] in your products.

Scan any cosmetic product with LuxSense to see if it contains Oxedrine [BAN] and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.